Company Monitoring Page for Otsuka

job ratings for Otsuka

02/06/21
industry:
Big Pharma
company:
Otsuka
job rating:
1
It’s bizarroworld.
11/15/20
industry:
Big Pharma
company:
Otsuka
job rating:
1
Seriously unqualified execs generating redundant work to look busy for Japan. Leadership looks the other way at middle mgmt’s incompetence. Work done mostly by contractors due to turnover. Miserable employees.
09/07/20
industry:
pharmaceutical sales
job title:
Sales rep - Nephrology
company:
Otsuka
job rating:
1
No pipeline. Highly unorganized. Inept Sr. Management. Poor leadership.
03/28/20
industry:
Big Pharma
job title:
sales rep
company:
Otsuka
job rating:
1
Assholes in management...micromanagment, incompetent execs, nothing new to talk about
01/29/20
industry:
Big Pharma
job title:
salesrep
company:
Otsuka
job rating:
1
Boring as hell, nothing new to talk about, stupid management
01/07/20
industry:
pharma
company:
Otsuka
job rating:
1
Poor leadership
07/28/19
industry:
Big Pharma
job title:
Neuroscience representative
company:
Otsuka
job rating:
1
Nothing new to talk about, no more access to doctors, more sales pressure
03/27/17
industry:
pharmaceutical sales
company:
Otsuka
job rating:
1
Culture; pipeline; upper management

latest headlines for company on cafepharma

Otsuka, Click trial digital depression therapy with Google
Pharmaforum
Thu, 02/25/21 - 09:44 am
Tags:
Otsuka, Click Therapeutics, Verily, Alphabet
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
Endpoints
Thu, 12/17/20 - 06:18 pm
Tags:
Aurinia Pharmaceuticals, lupus nephritis, GSK, Otsuka, Benlysta
Otsuka takes to YouTube, film and more to tackle the emerging mental health pandemic
Fierce Pharma
Mon, 10/19/20 - 10:37 am
Tags:
Otsuka, mental health, pandemic, YouTube
Palladio bags $20 million Series B to topple a problematic kidney disease drug
Endpoints
Fri, 09/25/20 - 10:33 am
Tags:
Palladio Biosciences, autosomal dominant polycystic kidney disease, kidney disease, lixivaptan, Otsuka, Samsca
Court approves Otsuka’s bid to buy Proteus for $15M
MedCity News
Fri, 08/21/20 - 12:34 pm
Tags:
M&A, Otsuka, Proteus Digital Health, bankruptcy, patient adherence
Armed with FDA nod, Otsuka unit Astex preps to launch oral chemotherapy Inqovi
Fierce Pharma
Mon, 08/3/20 - 10:24 am
Tags:
Otsuka, Astex, FDA, decitabine, blood cancer
FDA Approves At-Home Oral Therapy for MDS
Xtalks
Sat, 07/11/20 - 11:51 am
Tags:
FDA, Inqovi, MDS, CMML, Otsuka, Astex
Proteus files for bankruptcy: Where did it falter?
MedCity News
Wed, 06/17/20 - 10:01 am
Tags:
Proteus Digital Health, Otsuka, smart pills, bankruptcy
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
Xconomy
Wed, 03/11/20 - 07:26 pm
Tags:
LSP, life sciences, Bristol-Myers Squibb, Otsuka, Europe
A forerunner in ‘smart pills’ adopts a new tack as key pharma partnership unravels
Stat
Tue, 01/14/20 - 10:03 am
Tags:
smart pills, Proteus Digital Health, Otsuka
Otsuka's Avanir agrees to pay $108M over Neudexta kickbacks probe
Fierce Pharma
Thu, 09/26/19 - 07:44 pm
Tags:
Avanir Pharmaceuticals, Otsuka, kickbacks, Neudexta, dementia
"Smart Pill" Schizophrenia Drug Unlikely To Move Payers
Forbes
Mon, 07/22/19 - 10:03 am
Tags:
Otsuka, Abilify MyCite, smart pills, schizophrenia, payers
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
BioSpace
Fri, 06/7/19 - 10:07 pm
Tags:
Astex, Otsuka, clinical trials, ASTX727, myelodysplastic syndrome, CMML
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Tue, 05/21/19 - 11:07 pm
Tags:
Verily, Alphabet, clinical trials, Pfizer, Novartis, Sanofi, Otsuka
Wockhardt receives US FDA approval for cancer drug
Pharmaceutical Business Review
Fri, 04/12/19 - 10:09 am
Tags:
Wockhardt, decitabine, FDA, generics, Otsuka, Dacogen, myelodysplastic syndromes
3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop
Motley Fool
Sat, 03/30/19 - 12:44 pm
Tags:
Alzheimer's disease, Biogen, aducanumab, Otsuka, Axsome Therapeutics, Amgen, Novartis, Avanir, AVP-786, AXS-05, AMG520
Pfizer CNS spinout Cerevel brings on new CMO to launch phase 3 work in Parkinson’s disease
Fierce Biotech
Wed, 02/20/19 - 06:09 pm
Tags:
Cerevel Therapeutics, Pfizer, Otsuka, CMOs, Parkinson's Disease, epilepsy
Antipsychotic from Lundbeck, Otsuka flops again in PhIII trials — this time in bipolar patients
Endpoints
Thu, 02/14/19 - 05:45 pm
Tags:
Lundbeck, Otsuka, brexpiprazole, anti-psychotic, schizophrenia, bipolar disorder
Otsuka, Click to develop digital therapeutics for MDD
Pharmaceutical Business Review
Fri, 01/4/19 - 09:09 am
Tags:
Otsuka, Click Therapeutics, digital therapeutics, major depressive disorder
Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial
Fierce Biotech
Fri, 11/30/18 - 10:27 am
Tags:
Lundbeck, Otsuka, brexpiprazole-sertraline, PTSD, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.